Table 3 SARS-CoV-2 infection summary.

From: Neutralizing antibodies to SARS-CoV-2 variants of concern: a pediatric surveillance study

Variable

No vaccines

1 Vaccine

2 Vaccines

P Value

Total Participants from Cohort, n (%)

335 (54.1)

169 (27.3) ***

115 (18.6) *** †††

< 0.001

Swab Test, n (%)

   

0.040

Positive

49 (14.6)

26 (15.4)

8 (7.0) *

 

Negative

188 (56.1)

119 (70.4)

83 (72.2)

 

Nucleocapsid Antibody, n (%)

   

0.006

Positive

86 (25.7)

26 (15.4) *

17 (14.8) *

 

Negative

249 (74.3)

143 (84.6)

98 (85.2)

 

Swab Test or Nucleocapsid, n (%)

   

0.002

Positive

120 (35.8)

47 (27.8)

22 (19.1) **

 

Negative

215 (64.2)

122 (72.2)

93 (80.9)

 
  1. Note: P Value represents the Chi-square test of independence comparing the difference in proportions between the No Vaccines, 1 Vaccine, and 2 Vaccine groups. Post-hoc pairwise Chi-square Bonferroni adjusted P Values are shown as < 0.05 = * or †, < 0.01 = ** or ††, < 0.001 = *** or †††. Comparisons to the No Vaccine group are marked with *, while comparison between the 1 Vaccine and 2 Vaccine group are marked with †.
Back to article page